Exhibit 5.1
July
31, 2020
SunHydrogen,
Inc.
10
E. Yanonali, Suite 36
Santa
Barbara, CA 93101
Re:
Common Stock registered under Registration Statement on Form S-3
Ladies
and Gentlemen:
We have acted as counsel to SunHydrogen, Inc.,
a Nevada corporation (the “Company”), in connection with the Common Stock Purchase Agreement dated July 27, 2020 (the
“Purchase Agreement”) by and between the Company and Triton Funds LP (the “Investor”), relating to the
sale by the Company to the Investor of up to $2,100,000 of shares (the “Shares”) of the Company’s common stock,
par value $0.001 per share.
This
opinion is being delivered in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities
Act of 1933, as amended (the “Securities Act”).
In
connection with this opinion, we have examined originals or copies, certified or otherwise identified to our satisfaction, of
the following:
1.
Articles of Incorporation of the Company, as amended;
2.
Bylaws of the Company, as amended;
3.
The Purchase Agreement;
4.
Registration Statement on Form S-3 (Registration No. 333-239632) as filed by the Company with the Securities and Exchange
Commission (the “Commission”) on July 2, 2020 (as such registration statement became effective on July 8, 2020, the
“Registration Statement”) pursuant to the Securities Act;
5.
The prospectus supplement filed with the Commission on July 28, 2020, pursuant to Rule 424(b)(5) promulgated under the Securities
Act (the “Prospectus Supplement”), together with the base prospectus dated July 8, 2020; and
6.
Written consent of the Board of Directors of the Company approving the Purchase Agreement.
We
have also examined originals or copies, certified or otherwise identified to our satisfaction, of such records of the Company
and such agreements, certificates and receipts of public officials, certificates of officers or other representatives of the Company
and others, and such other documents as we have deemed necessary or appropriate as a basis for the opinions stated below.
In
our examination, we have assumed the genuineness of all signatures, including endorsements, the legal capacity and competency
of all natural persons, the authenticity of all documents submitted to us as originals, the conformity to original documents of
all documents submitted to us as facsimile, electronic, certified or photostatic copies, and the authenticity of the originals
of such copies. In making our examination of executed documents, we have assumed (i) that the parties thereto, other than
the Company, had the power, corporate or other, to enter into and perform all obligations thereunder and (ii) the due authorization
by all requisite action, corporate or other, and the execution and delivery by such parties of such documents, and the validity
and binding effect thereof on such parties.
1185 Avenue of the Americas
| 37th Floor | New York, NY | 10036
T (212) 930 9700 | F (212) 930 9725 | WWW.SRF.LAW
The
opinion expressed below is limited to the federal securities laws of the United States of America and the corporate laws of the
State of Nevada and we express no opinion as to the effect on the matters covered by the laws of any other jurisdiction.
Based
upon and subject to the foregoing, we are of the opinion that when the Shares have been delivered to and paid for by the Investor
as contemplated by the Purchase Agreement, the Shares will be duly authorized, validly issued, fully paid and non-assessable.
We
hereby consent to the filing of this opinion with the Commission as an exhibit to the Company’s Current Report on Form 8-K
being filed on the date hereof and incorporated by reference into the Registration Statement. We also hereby consent to the reference
to our firm under the caption “Legal Matters” in the Prospectus Supplement. In giving this consent, we do not thereby
admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules
and regulations of the Commission promulgated thereunder. This opinion is expressed as of the date hereof unless otherwise expressly
stated, and we disclaim any undertaking to advise you of any subsequent changes in the facts stated or assumed herein or of any
subsequent changes in applicable laws.
/s/
Sichenzia Ross Ference LLP
1185 Avenue of the Americas
| 37th Floor | New York, NY | 10036
T (212) 930 9700 | F (212) 930 9725 | WWW.SRF.LAW
Exhibit 10.1
COMMON STOCK PURCHASE
AGREEMENT
This Common Stock
Purchase Agreement (the “Agreement”), dated as of July 27, 2020 (the “Execution Date”), is entered
into by and between SunHydrogen, Inc., a Nevada corporation (the “Company”), and Triton Funds LP, a Delaware limited
partnership (the “Investor”).
RECITAL
WHEREAS, upon the
terms and subject to the conditions contained herein, the Investor agrees to purchase, and the Company agrees to sell, and the
Investor agrees to purchase, Two Million One Hundred Thousand Dollars ($2,100,000) of common stock, par value $0.001 per share
(the “Common Stock”), of the Company, which shares of Common Stock shall be registered under the Securities Act
of 1933, as amended (“1933 Act”) pursuant to an effective Registration Statement on Form S-3.
NOW THEREFORE,
in consideration of the foregoing recital, which shall be considered an integral part of this Agreement, the covenants and agreements
set forth hereafter, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the
Company and the Investor hereby agree as follows:
AGREEMENT
SECTION I
DEFINITIONS
For all purposes
of and under this Agreement, the following terms shall have the respective meanings below, and such meanings shall be equally applicable
to the singular and plural forms of such defined terms.
“1934 Act” shall mean
the Securities Exchange Act of 1934, as amended, or any similar federal statute, and the rules and regulations of the SEC thereunder,
all as the same will then be in effect.
“Business Day” shall mean
any day on which the Principal Market for the Purchased Shares is open for trading from the hours of 9:30 am until 4:00 pm eastern
time.
“Closing” shall mean
the closing of the purchase and sale of the Purchased Shares hereunder, which will occur on the date that is no later than two
(2) Business Days after the Purchase Notice Date.
“Commitment Period” shall
mean the period beginning on the Business Day immediately following the Execution Date and ending on the expiration of this Agreement.
“Floor Price” shall mean
the optional price determined by Company in Exhibit A; if Purchase Price is below Floor Price, Investor may elect to reduce Investment
Amount at Closing.
“Principal Market” shall
mean the New York Stock Exchange, the NYSE Amex, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select
Market or the OTC Markets, whichever is the market on which the Common Stock is listed.
“Purchase Notice” shall
mean the written notice sent to the Investor by the Company, which Purchase Notice shall state the total amount of Purchased Shares
that the Company intends to sell to the Investor pursuant to the terms of this Agreement based on the formula set forth in Section
2.1 hereof.
“Purchased Shares” shall
mean shares of Common Stock issued pursuant to the terms of this Agreement.
“Investment Amount” shall
mean the total dollar amount to be sold by the Company at the Closing, not to exceed Two Million One Hundred Thousand Dollars ($2,100,000).
“Investment Fee” shall
mean $5,000 that Issuer will pay Investor at the Closing.
“Registration Statement” means
the Registration Statement on Form S-3 filed with the SEC on July 2, 2020 and declared effective by the SEC on July 8, 2020 (including
the base prospectus included therein and any prospectus supplement thereto), registration number 333-239632, registering the Purchased
Shares issuable hereunder.
“SEC” shall mean the
U.S. Securities and Exchange Commission.
“Valuation
Cap” shall mean the market capitalization of the Company on the Execution Date; calculated by multiplying 2,180,067,917 by
0.068805195 – for the avoidance of doubt, One Hundred Fifty Million Dollars ($150,000,000).
SECTION II
PURCHASE AND SALE
OF COMMON STOCK
2.1 PURCHASE
AND SALE OF PURCHASED SHARES. Subject to the terms and conditions set forth herein, the Company shall sell to the Investor,
and the Investor shall purchase from the Company, that number of Purchased Shares set forth in the Purchase Notice. The Investment
Amount for any Purchase Notice will be the share amount set forth in the Purchase Notice delivered to Investor multiplied by the
Purchase Price, and the purchase price per share will be 85% of the lowest closing price of the Company’s Common Stock as
reported by the Principal Market during the five (5) Business Days prior to Closing (“Purchase Price”); not to exceed
the Valuation Cap.
2.2 DELIVERY
OF PURCHASE NOTICE. Subject to the terms and conditions herein, the Company in its sole discretion may deliver the Purchase
Notice to the Investor during the Commitment Period setting forth the total number of Purchased Shares to be purchased by Investor,
which Purchase Notice shall be in the form attached hereto as Exhibit A and incorporated herein by reference.
2.3 CONDITIONS
TO INVESTOR’S OBLIGATIONS. Notwithstanding anything to the contrary in this Agreement, the Investor shall not be obligated
to purchase any Purchased Shares at the Closing unless each of the following conditions are satisfied:
|
|
(i)
|
the Registration Statement shall remain effective and available for sale of the Purchased Shares at all times until the Closing;
|
|
|
(ii)
|
at the Closing, the Common Stock shall have been listed or quoted for trading on the Principal Market and shall not have been
suspended from trading, at any time, after the Execution Date and the Company shall not have been notified of any pending or threatened
proceeding or other action to suspend the trading of the Common Stock;
|
|
|
(iii)
|
no injunction shall have been issued and remain in force,
or action commenced by a governmental authority which has not been stayed or abandoned, prohibiting the purchase or the
issuance of the Purchased Shares; and
|
|
|
(iv)
|
the issuance of the Purchased Shares will not violate any requirements of the Principal Market.
|
If any of the events described in clauses
(i) through (iv) above occurs prior to the Closing, then the Investor shall have no obligation to purchase the Purchased Shares
set forth in the Purchase Notice.
2.4 MECHANICS
OF PURCHASE OF PURCHASED SHARES BY INVESTOR. The Closing of the purchase of the Purchased Shares set forth in the Purchase
Notice shall occur no later than two (2) Business Days following the receipt by Investor’s custodian of the Purchased Shares
(the “Purchase Notice Date”). At the Closing, the Investor shall deliver the Investment Amount by wire transfer
of immediately available funds to an account designated by the Company set forth in the Purchase Notice. In addition, on or prior
to the Closing, each of the Company and Investor shall deliver to each other all documents, instruments and writings required to
be delivered or reasonably requested by either of them pursuant to this Agreement in order to implement and effect the transactions
contemplated herein.
2.5 LIMITATION
ON AMOUNT OF OWNERSHIP. Notwithstanding anything to the contrary in this Agreement, in no event shall the Investor be entitled
to purchase that number of Purchased Shares, which when added to the sum of the number of shares of Common Stock beneficially owned
(as such term is defined under Section 13(d) and Rule 13d-3 of the 1934 Act), by the Investor, would exceed 9.9% of the number
of shares of Common Stock outstanding on the Purchase Notice Date, as determined in accordance with Rule 13d-1(j) of the 1934 Act.
SECTION III
INVESTOR’S
REPRESENTATIONS, WARRANTIES AND COVENANTS
By executing this
Agreement, the Investor represents, warrants and agrees that:
3.1 POWER AND
AUTHORITY. The undersigned has full power and authority to act on behalf of and bind the Investor to its obligations
as set forth herein and making these representations, warranties and agreements. This Agreement has been duly executed by the Investor,
and constitutes the valid and legally binding obligation of the Investor, enforceable against it in accordance with its terms,
except as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization,
moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement of creditors’ rights and remedies.
3.2 EFFECTIVE
REGISTRATION STATEMENT. The Purchased Shares are being offered pursuant to the Registration Statement and Investor is
solely relying on the Registration Statement and all periodic filings made by the Company under the 1934 Act (“SEC Filings”),
in determining whether to purchase the Purchased Shares.
3.3 REVIEW OF
SEC FILINGS; NO LEGAL ADVICE FROM THE COMPANY. Investor has had full opportunity to read and review the Registration
Statement, the documents incorporated therein by reference, and consult with an attorney regarding such Registration Statement.
3.4 ACCURACY
OF REPRESENTATIONS. The information provided herein and these representations, warranties and agreements are accurate
and complete, and shall remain so until the undersigned notifies the Company otherwise.
3.5 NO SHORT
SALES. Neither Investor nor its affiliates shall engage in any short sales or similar transactions following the date
of execution of this Agreement until termination of the Commitment Period.
SECTION IV
REPRESENTATIONS
AND WARRANTIES OF THE COMPANY
Except as disclosed
on the Company’s SEC Filings, the Company represents and warrants to the Investor that:
4.1 ORGANIZATION
AND QUALIFICATION. The Company is a corporation duly organized and validly existing in good standing under the laws of the
State of Nevada and has the requisite corporate power and authorization to own its properties and to carry on its business as now
being conducted. The Company is duly qualified to do business and is in good standing in every jurisdiction in which its ownership
of property or the nature of the business conducted by it makes such qualification necessary, except to the extent that the failure
to be so qualified or be in good standing would not have a Material Adverse Effect. As used in this Agreement, “Material
Adverse Effect” means a change, event, circumstance, effect or state of facts that has had or is reasonably likely to
have, a material adverse effect on the business, properties, assets, operations, results of operations, financial condition or
prospects of the Company or on the transactions contemplated hereby or by the agreements and instruments to be entered into in
connection herewith, or on the authority or ability of the Company to perform its obligations under the Agreement.
4.2 AUTHORIZATION;
ENFORCEMENT; COMPLIANCE WITH OTHER INSTRUMENTS.
|
|
(i)
|
The Company has the requisite corporate power and authority to enter into the Agreement and to issue the Purchased Shares in
accordance with the terms hereof and thereof.
|
|
|
(ii)
|
The execution and delivery of the Agreement by the Company and the consummation by it of the transactions contemplated hereby
and thereby, including without limitation the issuance of the Purchased Shares pursuant to this Agreement, have been duly and validly
authorized by the Company’s Board of Directors and no further consent or authorization is required by the Company, its Board
of Directors, or its shareholders.
|
|
|
(iii)
|
The Agreement has been duly and validly executed and delivered by the Company.
|
|
|
(iv)
|
The Agreements constitute the valid and binding obligations of the Company enforceable against the Company in accordance with
their terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement of creditors’ rights
and remedies.
|
4.3 ISSUANCE
OF SHARES. The Company has reserved the amount of Purchased Shares included in the Registration Statement for issuance pursuant
to the Agreement, which have been duly authorized and reserved (subject to adjustment pursuant to the Company’s covenant
set forth in Section 5.5 below) pursuant to this Agreement. Upon issuance in accordance with this Agreement, the
Purchased Shares will be validly issued, fully paid for and non-assessable and free from all taxes, liens and charges with respect
to the issuance thereof. In the event the Company cannot register a sufficient number of Purchased Shares for issuance pursuant
to this Agreement, the Company will use its best efforts to authorize and reserve for issuance the number of Purchased Shares required
for the Company to perform its obligations hereunder as soon as reasonably practicable.
4.4 DILUTIVE
EFFECT. The Company’s executive officers and directors have studied and fully understand the nature of the transactions
contemplated by this Agreement and recognize that the issuance of the Purchased Shares will have a dilutive effect on the shareholders
of the Company. The Board of Directors of the Company has concluded, in its good faith business judgment, and with full understanding
of the implications, that such issuance is in the best interests of the Company. The Company specifically acknowledges that, subject
to such limitations as are expressly set forth in the Agreement, its obligation to issue shares of Common Stock pursuant to this
Agreement is absolute and unconditional regardless of the dilutive effect that such issuance may have on the ownership interests
of other shareholders of the Company.
SECTION V
COVENANTS OF THE
COMPANY
5.1 BEST EFFORTS.
The Company shall use all commercially reasonable efforts to timely satisfy each of the conditions set forth in this Agreement.
5.2 REPORTING
STATUS. Until one of the following occurs, the Company shall file all reports required to be filed with the SEC pursuant to
the 1934 Act, and the Company shall not terminate its status, or take an action or fail to take any action, which would terminate
its status as a reporting company under the 1934 Act: (i) this Agreement terminates pursuant to Section 8 and
the Investor has the right to sell all of the Purchased Shares, or (ii) the date on which the Investor has sold all the Purchased
Shares.
5.3 USE OF PROCEEDS.
The Company will use the proceeds from the sale of the Purchased Shares for general corporate and working capital purposes and
acquisitions or assets, businesses or operations or for other purposes that the Board of Directors, in good faith deem to be in
the best interest of the Company.
5.4 FINANCIAL
INFORMATION. During the Commitment Period, the Company agrees to make available to the Investor via EDGAR or other electronic
means the following documents and information on the forms set forth: (i) its Annual Reports on Form 10-K, its Quarterly Reports
on Form 10-Q, any Current Reports on Form 8-K and any Registration Statements or amendments filed pursuant to the 1933 Act; (ii)
copies of any notices and other information made available or given to the shareholders of the Company generally, contemporaneously
with the making available or giving thereof to the shareholders; and (iii) within two (2) calendar days of filing or delivery thereof,
copies of all documents filed by the Company with, and all correspondence sent by the Company to, the Principal Market, any securities
exchange or market, or the Financial Industry Regulatory Association, unless such information is material nonpublic information.
5.5 RESERVATION
OF PURCHASED SHARES. The Company shall take all action necessary to at all times have authorized and reserved the amount of
Purchased Shares included in the Registration Statement for issuance pursuant to the Agreement. In the event that the Company determines
that it does not have a sufficient number of authorized shares of Common Stock to reserve and keep available for issuance as described,
the Company shall use all commercially reasonable efforts to increase the number of authorized shares of Common Stock by seeking
shareholder approval for the authorization of such additional shares.
5.6 LISTING.
The Company shall maintain the listing of all of the Purchased Shares on the Principal Market and each other national securities
exchange and automated quotation system, if any, upon which shares of Common Stock are then listed (subject to official notice
of issuance) and shall maintain, such listing of all Purchased Shares issuable under the terms of the Agreement. The Company shall
not take any action which would be reasonably expected to result in the delisting or suspension of the Common Stock on the Principal
Market (excluding suspensions of not more than one (1) Business Day resulting from business announcements by the Company). The
Company shall promptly provide to the Investor copies of any notices it receives from the Principal Market regarding the continued
eligibility of the Common Stock for listing on such automated quotation system or securities exchange. The Company shall pay all
fees and expenses in connection with satisfying its obligations under this Section 5.6.
5.7 CORPORATE
EXISTENCE. The Company shall use all commercially reasonable efforts to preserve and continue the corporate existence of the
Company.
5.8 NOTICE OF
CERTAIN EVENTS AFFECTING REGISTRATION. The Company shall promptly notify the Investor upon the occurrence of any of the following
events in respect of a Registration Statement or related prospectus in respect of an offering of the Purchased Shares: (i) receipt
of any request for additional information by the SEC or any other federal or state governmental authority during the period of
effectiveness of the Registration Statement for amendments or supplements to the Registration Statement or related prospectus;
(ii) the issuance by the SEC or any other federal or state governmental authority of any stop order suspending the effectiveness
of any Registration Statement or the initiation of any proceedings for that purpose; (iii) receipt of any notification with respect
to the suspension of the qualification or exemption from qualification of any of the Purchased Shares for sale in any jurisdiction
or the initiation or notice of any proceeding for such purpose; (iv) the happening of any event that makes any statement made in
such Registration Statement or related prospectus or any document incorporated or deemed to be incorporated therein by reference
untrue in any material respect or that requires the making of any changes in the Registration Statement, related prospectus or
documents so that, in the case of a Registration Statement, it will not contain any untrue statement of a material fact or omit
to state any material fact required to be stated therein or necessary to make the statements therein not misleading, and that in
the case of the related prospectus, it will not contain any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading; and (v) the Company’s reasonable determination that a post-effective amendment or supplement to the
Registration Statement would be appropriate, and the Company shall promptly make available to Investor any such supplement or amendment
to the related prospectus.
5.9 TRANSFER
AGENT. The Company shall deliver instructions to its transfer agent to issue Purchased Shares to the Investor that are issued
to the Investor pursuant to the Agreement.
5.10 ACKNOWLEDGEMENT
OF TERMS. The Company hereby represents and warrants to the Investor that: (i) it is voluntarily entering into this Agreement
of its own free will, (ii) it is not entering this Agreement under economic duress, (iii) the terms of this Agreement are reasonable
and fair to the Company, and (iv) the Company has had independent legal counsel of its own choosing review this Agreement, advise
the Company with respect to this Agreement, and represent the Company in connection with this Agreement.
SECTION VI
EXPIRATION
This Agreement
shall expire upon the earlier to occur of:
6.1 that date
when the Investor has purchased an aggregate of Two Million One Hundred Thousand Dollars ($2,100,000) in Purchased Shares pursuant
to this Agreement; or
6.2 September
30, 2020.
Any and all Purchased
Shares issuable to Investor, or penalties or other amounts, if any, due under this Agreement shall be immediately payable and due
Investor upon expiration of this Agreement.
SECTION VII
INDEMNIFICATION
In consideration
of the parties mutual obligations set forth in the Agreement, the Company (the “Indemnitor”) shall defend, protect,
indemnify and hold harmless the Investor and all of the investor’s shareholders, officers, directors, employees, counsel,
and direct or indirect investors and any of the foregoing person’s agents or other representatives (including, without limitation,
those retained in connection with the transactions contemplated by this Agreement) (collectively, the “Indemnitees”)
from and against any and all actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages,
and reasonable expenses in connection therewith (irrespective of whether any such Indemnitee is a party to the action for which
indemnification hereunder is sought), and including reasonable attorneys’ fees and disbursements (the “Indemnified
Liabilities”), incurred by any Indemnitee as a result of, or arising out of, or relating to (I) any misrepresentation or
breach of any representation or warranty made by the Indemnitor in this Agreement or any other certificate, instrument or document
contemplated hereby or thereby; (II) any breach of any covenant, agreement or obligation of the Indemnitor contained in the Agreement
or any other certificate, instrument or document contemplated hereby or thereby; or (III) any cause of action, suit or claim brought
or made against such Indemnitee by a third party and arising out of or resulting from the execution, delivery, performance or enforcement
of the Agreement or any other certificate, instrument or document contemplated hereby or thereby, except insofar as any such misrepresentation,
breach or any untrue statement, alleged untrue statement, omission or alleged omission is made in reliance upon and in conformity
with information furnished to Indemnitor which is specifically intended for use in the preparation of any such Registration Statement,
preliminary prospectus, prospectus or amendments to the prospectus, and unless such action is based upon a breach of such Purchaser
Party’s representations, warranties or covenants under this Agreement or any violations by such Indemnitee of state or federal
securities laws or any conduct by such Indemnitee which constitutes fraud, gross negligence, willful misconduct or malfeasance.
To the extent that the foregoing undertaking by the Indemnitor may be unenforceable for any reason, the Indemnitor shall make the
maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities which is permissible under applicable
law. The indemnity provisions contained herein shall be in addition to any cause of action or similar rights Indemnitor may have,
and any liabilities the Indemnitor or the Indemnitees may be subject to.
SECTION VIII
GOVERNING LAW;
DISPUTES SUBMITTED TO ARBITRATION
8.1 LAW GOVERNING
THIS AGREEMENT. This Agreement shall be governed by and construed in accordance with the laws of the State of Nevada without
regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated
by this Agreement shall be brought only in the state or federal courts located in Los Angeles, California. The parties to this
Agreement hereby irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder and shall not assert
any defense based on lack of jurisdiction or venue or based upon forum non conveniens. The parties executing this Agreement
and other agreements referred to herein or delivered in connection herewith on behalf of the Company agree to submit to the in
personam jurisdiction of such courts and hereby irrevocably waive trial by jury. The prevailing party shall be entitled to
recover from the other party its reasonable attorney’s fees and costs. In the event that any provision of this Agreement
or any other agreement delivered in connection herewith is invalid or unenforceable under any applicable statute or rule of law,
then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform
with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the
validity or enforceability of any other provision of any agreement. Each party hereby irrevocably waives personal service of process
and consents to process being served in any suit, action or proceeding in connection with this Agreement by mailing a copy thereof
via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices
to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.
Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.
8.2 LEGAL FEES;
AND MISCELLANEOUS FEES. Except as otherwise set forth in the Agreement (including the Investment Fee), each party shall pay
the fees and expenses of its advisers, counsel, the accountants and other experts, if any, and all other expenses incurred by such
party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. Any attorneys’ fees
and expenses incurred by either the Company or the Investor in connection with the preparation, negotiation, execution and delivery
of any amendments to this Agreement or relating to the enforcement of the rights of any party, after the occurrence of any breach
of the terms of this Agreement by another party or any default by another party in respect of the transactions contemplated hereunder,
shall be paid on demand by the party which breached this Agreement and/or defaulted, as the case may be. The Company shall pay
all stamp and other taxes and duties levied in connection with the issuance of any Purchased Shares.
8.3 SURVIVAL.
The representations and warranties of the Company and the Investor contained in this Agreement shall survive the Commitment Period
and the expiration of this Agreement.
8.4 PRICING
OF COMMON STOCK. For purposes of this Agreement, the price of the Common Stock shall be determined by the formula set forth
in Section 2.1 hereof.
SECTION IX
NON-DISCLOSURE
OF NON-PUBLIC INFORMATION
The Company shall
not disclose non-public information to the Investor.
[Signature
page follows.]
IN WITNESS WHEREOF,
the undersigned have caused this Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.
|
TRITON FUNDS LP
|
|
|
|
|
|
By:
|
/s/ Jared Alexandria
|
|
|
Name:
|
Jared Alexandria
|
|
|
Title:
|
Authorized Signatory
|
|
|
|
|
|
SUNHYDROGEN, INC.
|
|
|
|
|
|
By:
|
/s/ Timothy Young
|
|
|
Name:
|
Timothy Young
|
|
|
Title:
|
Chief Executive Officer and President
|
|
EXHIBIT A
PURCHASE NOTICE
Date: _____, 2020
TRITON FUNDS LP,
This is to inform
you that as of today the Company hereby elects to exercise its right pursuant to this Agreement to require you to purchase _____
Purchased Shares for an Investment Amount equal to the number of shares purchased multiplied by the Purchase Price. The Company’s
wire instructions are as follows:
[Insert Wire
Instructions]
The price per
Purchased Share shall be calculated in accordance with the terms and conditions set forth in Section 2.1 of the Agreement.
Floor Price (optional):
_____
Regards,
|
SUNHYDROGEN, INC.
|
|
|
|
|
|
By:
|
|
|
|
Name:
|
Timothy Young
|
|
|
Title:
|
Chief Executive Officer and President
|
|